NCT05898412 Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya Status COMPLETED Phase N/A
NCT05892926 HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia Status COMPLETED Phase N/A
NCT05891847 Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05888857 MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. Status NOT_YET_RECRUITING Phase PHASE2
NCT05888207 A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT05887011 CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05886244 Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China Status COMPLETED Phase PHASE3
NCT05885009 Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102) Status RECRUITING Phase N/A
NCT05883644 Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05877599 A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation Status RECRUITING Phase PHASE1
NCT05876351 Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China Status COMPLETED Phase PHASE3
NCT05872958 Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study Status COMPLETED Phase PHASE1
NCT05866276 To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients Status COMPLETED Phase N/A
NCT05864391 A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH. Status TERMINATED Phase PHASE1
NCT05862545 Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol) Status COMPLETED Phase N/A
NCT05859048 Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure Status RECRUITING Phase NA
NCT05850494 Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma Status COMPLETED Phase PHASE3
NCT05850234 AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1) Status RECRUITING Phase PHASE1/PHASE2
NCT05848843 A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations Status WITHDRAWN Phase PHASE1
NCT05848440 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants Status COMPLETED Phase PHASE1